Quarterly report pursuant to Section 13 or 15(d)

Convertible Notes Payable (Details Narrative)

v3.10.0.1
Convertible Notes Payable (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 9 Months Ended
May 21, 2018
May 03, 2018
Jan. 31, 2018
Nov. 24, 2017
May 31, 2018
Sep. 30, 2018
Sep. 30, 2017
Convertible note interest rate, percentage 8.00%            
Gross proceeds from convertible debt           $ 7,684 $ 3,000
Proceeds from public offering   $ 8,000          
Debt conversion converted instrument, shares issued 1,085,105            
Board of Directors [Member]              
Convertible note interest rate, percentage         8.00%    
Debt conversion price per share         $ 1.90    
Proceeds from public offering         $ 8,000    
Debt conversion converted instrument, shares issued         1,085,105    
Accrued interest         $ 2,062    
Securities Purchase Agreement [Member] | Convertible Notes Payable [Member] | OPKO Health, Inc. [Member]              
Debt instrument, principal amount     $ 1,000        
Convertible note interest rate, percentage     8.00%        
Debt maturity date     Jan. 31, 2020        
Debt conversion price per share     $ 8.10        
Gross proceeds from convertible debt     $ 10,000        
Securities Purchase Agreement [Member] | Two Accredited Investors [Member] | Convertible Notes [Member]              
Debt instrument, principal amount       $ 1,000      
Convertible note interest rate, percentage       8.00%      
Debt maturity date       Nov. 24, 2019      
Debt conversion price per share       $ 8.10      
Gross proceeds from convertible debt       $ 10,000